Open Access

Stromal cell-derived factor-1 promotes human adipose tissue-derived stem cell survival and chronic wound healing

  • Authors:
    • Qiang Li
    • Yanping Guo
    • Feifei Chen
    • Jing Liu
    • Peisheng Jin
  • View Affiliations

  • Published online on: May 4, 2016     https://doi.org/10.3892/etm.2016.3309
  • Pages: 45-50
  • Copyright: © Li et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Adipose tissue-derived stem cells (ADSCs) hold great potential for the stem cell-based therapy of cutaneous wound healing. Stromal cell‑derived factor‑1 (SDF-1) activates CXC chemokine receptor (CXCR)4+ and CXCR7+ cells and plays an important role in wound healing. Increasing evidence suggests a critical role for SDF‑1 in cell apoptosis and the survival of mesenchymal stem cells. However, the function of SDF‑1 in the apoptosis and wound healing ability of ADSCs is not well understood. The aim of this study was to analyze the effect of SDF‑1 on the apoptosis and therapeutic effect of ADSCs in cutaneous chronic wounds in vitro and in vivo. By flow cytometric analysis, it was found that hypoxia and serum free promoted the apoptosis of ADSCs. When pretreated with SDF‑1, the apoptosis of ADSCs induced by hypoxia and serum depletion was partly recovered. Furthermore, in vivo experiments established that the post-implantation cell survival and chronic wound healing ability of ADSCs were increased following pretreatment with SDF-1 in a diabetic mouse model of chronic wound healing. To explore the potential mechanism underlying the effect of SDF-1 on ADSC apoptosis, western blot analysis was employed and the results indicate that SDF‑1 may protect against cell apoptosis in hypoxic and serum‑free conditions through activation of the caspase signaling pathway in ADSCs. This study provides evidence that SDF‑1 pretreatment can increase the therapeutic effect of ADSCs in cutaneous chronic wounds in vitro and in vivo.
View Figures
View References

Related Articles

Journal Cover

July-2016
Volume 12 Issue 1

Print ISSN: 1792-0981
Online ISSN:1792-1015

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Li Q, Guo Y, Chen F, Liu J and Jin P: Stromal cell-derived factor-1 promotes human adipose tissue-derived stem cell survival and chronic wound healing. Exp Ther Med 12: 45-50, 2016.
APA
Li, Q., Guo, Y., Chen, F., Liu, J., & Jin, P. (2016). Stromal cell-derived factor-1 promotes human adipose tissue-derived stem cell survival and chronic wound healing. Experimental and Therapeutic Medicine, 12, 45-50. https://doi.org/10.3892/etm.2016.3309
MLA
Li, Q., Guo, Y., Chen, F., Liu, J., Jin, P."Stromal cell-derived factor-1 promotes human adipose tissue-derived stem cell survival and chronic wound healing". Experimental and Therapeutic Medicine 12.1 (2016): 45-50.
Chicago
Li, Q., Guo, Y., Chen, F., Liu, J., Jin, P."Stromal cell-derived factor-1 promotes human adipose tissue-derived stem cell survival and chronic wound healing". Experimental and Therapeutic Medicine 12, no. 1 (2016): 45-50. https://doi.org/10.3892/etm.2016.3309